Neutrophil Gelatinase-Associated
Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: A cross-sectional study and the effects of lisinopril.
NGAL, a member of the
lipocalin family, is secreted from kidney proximal tubuli after ischemic damage.
Urinary neutrophil gelatinase-associated
lipocalin is associated with heavy metal exposure in welding workers.
The urine levels of the glomerular and tubular injury biomarkers such as podocalyxin, nephrin, podocin, neutrophil gelatinase-associated
lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and tissue inhibitor of metalloproteinase-2 (TIMP-2) were measured by ELISA methods.
Neutrophil gelatinase associated
lipocalin (NGAL) is a highly predictive biomarker of AKI (22).
However, there was no significant difference in the changes of plasma neutrophil gelatinase-associated
lipocalin (NGAL) (a highly sensitive biomarker of AKI) levels between RIPC and control groups.
Human neutrophil
lipocalin (HNL), originating from the neutrophils, has been shown to be useful in sepsis, but, so far, the number of relevant studies is limited.
This winning combination significantly outperformed neutrophil gelatinase-associated
lipocalin, activated partial thromboplastin time, and resistin, both individually and in various combinations, for the vital task of making a rapid distinction between infectious and noninfectious causes of pediatric systemic inflammatory response syndrome, reported Enitan D.
(7) Lipocalin-2 (LCN2) located on the 9th chromosome cytogenetic band 9q43.11 is associated with
lipocalin (NGAL) and is known as the neutrophil gelatinase (8) on the 9th chromosome cytogenetic band 9q43.11.
Several novel biomarkers have shown promising results in predicting AKI after cardiac procedures: neutrophil gelatinase-associated
lipocalin (NGAL), which is involved in the innate immune system and allows earlier detection of AKI than SCr; kidney injury molecule-1 (KIM-1), a type-1 transmembrane protein; and interleukin-18 (IL-18), a proinflammatory cytokine that plays a role in both the innate and acquired immune response.
BioPorto A/S (CPH: BIOPOR), an in-vitro diagnostics company, announced on Friday that it has entered into a global distribution agreement with Roche (VTX:ROG), under which BioPorto will deliver a neutrophil gelatinase-associated
lipocalin (NGAL) test for use on Roche's cobas c 501/c 502 analysers.